Medical and Hospital News
SPACE MEDICINE
Musk's Neuralink says cleared for human test of brain implants
Musk's Neuralink says cleared for human test of brain implants
By Glenn CHAPMAN
San Francisco (AFP) May 26, 2023

Elon Musk's start-up Neuralink on Thursday said it has approval from US regulators to test its brain implants in people.

Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is "an important first step" for its technology, which is intended to let brains interface directly with computers.

"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Musk-run Twitter.

Recruitment for a clinical trial is not yet open, according to Neuralink.

The aim of Neuralink implants is to enable human brains to communicate directly with computers, Musk said during a presentation by the start-up in December.

"We've been working hard to be ready for our first human (implant), and obviously we want to be extremely careful and certain that it will work well before putting a device in a human," he said at the time.

Neuralink prototypes, which are the size of a coin, have been implanted in the skulls of monkeys, demonstrations by the startup showed.

At a presentation, Neuralink showed several monkeys "playing" basic video games or moving a cursor on a screen through their Neuralink implant.

The technology has also been tested in pigs.

With the help of a surgical robot, a piece of the skull is replaced with a Neuralink disk, and its wispy wires are strategically inserted into the brain, an early demonstration showed.

The disk registers nerve activity, relaying the information via common Bluetooth wireless signal to a device such as a smartphone, according to Musk.

"It actually fits quite nicely in your skull," Musk said during a prior presentation.

"It could be under your hair and you wouldn't know."

- Uploading memories? -

Musk said the company would try to use the implants to restore vision and mobility in humans who had lost such abilities.

"We would initially enable someone who has almost no ability to operate their muscles... and enable them to operate their phone faster than someone who has working hands," he said.

"As miraculous as it may sound, we are confident that it is possible to restore full body functionality to someone who has a severed spinal cord," he said.

Beyond the potential to treat neurological diseases, Musk's ultimate goal is to ensure that humans are not intellectually overwhelmed by artificial intelligence (AI), he said.

Other companies working on similar systems include Synchron, which announced in July that it had implanted the first human brain-machine interface in the United States.

Members of the Neuralink team have shared a "wish list" that ranged from technology returning mobility to the paralyzed and sight to the blind, to enabling telepathy and the uploading of memories for later reference -- or perhaps to be downloaded into replacement bodies.

Meanwhile, Musk recently established a business devoted to developing sophisticated AI. The boss of Tesla has also predicted that autonomous driving technology at the electric car maker is heading for a breakthrough.

Musk has contended that synching minds with machines is vital if people are going to avoid being so outpaced by AI that, under the best of circumstances, humans would be akin to "house cats."

Experts and academics remain cautious about his vision of symbiotically merging minds with super-powered computing.

Related Links
Space Medicine Technology and Systems

Subscribe Free To Our Daily Newsletters
Tweet

RELATED CONTENT
The following news reports may link to other Space Media Network websites.
SPACE MEDICINE
UCSD to test cancer drugs in space using private astronaut mission
San Diego CA (SPX) May 24, 2023
On May 21, 2023, scientists at University of California San Diego Sanford Stem Cell Institute launched several new nanobioreactor experiments onto the International Space Station (ISS) via the second Axiom Space Private Astronaut Mission, Axiom Mission 2 (Ax-2). The latest experiments expand their research on human stem cell aging, inflammation and cancer in low Earth orbit. Increasing evidence shows that microgravity conditions can accelerate aging, inflammation and immune dysfunction in human st ... read more

SPACE MEDICINE
Children in quake-hit Syria learn in buses turned classrooms

As 'Blue Helmets' turn 75, chief laments UN divisions

On the edge: DR Congo city stalked by fear of landslides

UN urges Myanmar junta to open up to Cyclone Mocha relief

SPACE MEDICINE
GPS tracking reveals how a female baboon stopped using urban space after giving birth

Royal navy tests quantum sensor for future navigation systems

Value of Chinese satellite navigation system increases as service expands

Beidou launches fifty-sixth Beidou navigation satellite

SPACE MEDICINE
Serotonin's impact across molecular and whole-brain levels in a simple animal

Oldest architectural plans detail mysterious desert mega structures

Evidence of Ice Age human migrations from China to the Americas and Japan

Scientists reveal more inclusive update to human genome

SPACE MEDICINE
Protecting India's tigers also good for climate: study

Weeds grow at London's Chelsea Flower Show

'Mini kangaroos' hop back in South Australia

S.African taxidermists fret at UK hunting trophy ban

SPACE MEDICINE
13 dead from Congo haemorrhagic fever in Iraq this year

Study: Covid-19 has reduced diverse urban interactions

Vaccine printer could help vaccines reach more people

Mozambique cholera cases surge tenfold after cyclone

SPACE MEDICINE
Chinese comedy group punishment sends chills through arts sphere

Chinese diaspora bears brunt of Canada-Beijing tensions

Pope offers support for Catholics in China

Envy in Papua New Guinea as Chinese money pours in

SPACE MEDICINE
Malaysia searches Chinese ship suspected of looting WWII wrecks

People smugglers use TikTok to promote their services

Colombia's Petro accuses Gulf Clan cartel of breaking ceasefire

Ecuadoran soldier killed in clash with drug traffickers

SPACE MEDICINE
Subscribe Free To Our Daily Newsletters




The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.